Global Nuclear Drug for Therapeutic Market Size, Status and Forecast 2024-2031

Report ID: 922388 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Radium-223
        1.2.3 Lutetium-177
        1.2.4 Iodine-131
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Nuclear Drug for Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Thyroid
        1.3.3 Bone Metastasis
        1.3.4 Lymphoma
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Nuclear Drug for Therapeutic Market Perspective (2016-2027)
    2.2 Nuclear Drug for Therapeutic Growth Trends by Regions
        2.2.1 Nuclear Drug for Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Nuclear Drug for Therapeutic Historic Market Share by Regions (2016-2021)
        2.2.3 Nuclear Drug for Therapeutic Forecasted Market Size by Regions (2022-2027)
    2.3 Nuclear Drug for Therapeutic Industry Dynamic
        2.3.1 Nuclear Drug for Therapeutic Market Trends
        2.3.2 Nuclear Drug for Therapeutic Market Drivers
        2.3.3 Nuclear Drug for Therapeutic Market Challenges
        2.3.4 Nuclear Drug for Therapeutic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Nuclear Drug for Therapeutic Players by Revenue
        3.1.1 Global Top Nuclear Drug for Therapeutic Players by Revenue (2016-2021)
        3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2016-2021)
    3.2 Global Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Nuclear Drug for Therapeutic Revenue
    3.4 Global Nuclear Drug for Therapeutic Market Concentration Ratio
        3.4.1 Global Nuclear Drug for Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nuclear Drug for Therapeutic Revenue in 2020
    3.5 Nuclear Drug for Therapeutic Key Players Head office and Area Served
    3.6 Key Players Nuclear Drug for Therapeutic Product Solution and Service
    3.7 Date of Enter into Nuclear Drug for Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Drug for Therapeutic Breakdown Data by Type
    4.1 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2016-2021)
    4.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2022-2027)

5 Nuclear Drug for Therapeutic Breakdown Data by Application
    5.1 Global Nuclear Drug for Therapeutic Historic Market Size by Application (2016-2021)
    5.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Nuclear Drug for Therapeutic Market Size (2016-2027)
    6.2 North America Nuclear Drug for Therapeutic Market Size by Type
        6.2.1 North America Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
        6.2.2 North America Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
        6.2.3 North America Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
    6.3 North America Nuclear Drug for Therapeutic Market Size by Application
        6.3.1 North America Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
        6.3.2 North America Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
        6.3.3 North America Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
    6.4 North America Nuclear Drug for Therapeutic Market Size by Country
        6.4.1 North America Nuclear Drug for Therapeutic Market Size by Country (2016-2021)
        6.4.2 North America Nuclear Drug for Therapeutic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Nuclear Drug for Therapeutic Market Size (2016-2027)
    7.2 Europe Nuclear Drug for Therapeutic Market Size by Type
        7.2.1 Europe Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
        7.2.2 Europe Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
        7.2.3 Europe Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
    7.3 Europe Nuclear Drug for Therapeutic Market Size by Application
        7.3.1 Europe Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
        7.3.2 Europe Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
        7.3.3 Europe Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
    7.4 Europe Nuclear Drug for Therapeutic Market Size by Country
        7.4.1 Europe Nuclear Drug for Therapeutic Market Size by Country (2016-2021)
        7.4.2 Europe Nuclear Drug for Therapeutic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size (2016-2027)
    8.2 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type
        8.2.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application
        8.3.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region
        8.4.1 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Nuclear Drug for Therapeutic Market Size (2016-2027)
    9.2 Latin America Nuclear Drug for Therapeutic Market Size by Type
        9.2.1 Latin America Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
        9.2.2 Latin America Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
        9.2.3 Latin America Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
    9.3 Latin America Nuclear Drug for Therapeutic Market Size by Application
        9.3.1 Latin America Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
        9.3.2 Latin America Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
        9.3.3 Latin America Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
    9.4 Latin America Nuclear Drug for Therapeutic Market Size by Country
        9.4.1 Latin America Nuclear Drug for Therapeutic Market Size by Country (2016-2021)
        9.4.2 Latin America Nuclear Drug for Therapeutic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size (2016-2027)
    10.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type
        10.2.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application
        10.3.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country
        10.4.1 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Details
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Nuclear Drug for Therapeutic Introduction
        11.1.4 Bayer Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.1.5 Bayer Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Nuclear Drug for Therapeutic Introduction
        11.2.4 Novartis Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 China Isotope & Radiation
        11.3.1 China Isotope & Radiation Company Details
        11.3.2 China Isotope & Radiation Business Overview
        11.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Introduction
        11.3.4 China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.3.5 China Isotope & Radiation Recent Development
    11.4 Dongcheng
        11.4.1 Dongcheng Company Details
        11.4.2 Dongcheng Business Overview
        11.4.3 Dongcheng Nuclear Drug for Therapeutic Introduction
        11.4.4 Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.4.5 Dongcheng Recent Development
    11.5 Q BioMed
        11.5.1 Q BioMed Company Details
        11.5.2 Q BioMed Business Overview
        11.5.3 Q BioMed Nuclear Drug for Therapeutic Introduction
        11.5.4 Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.5.5 Q BioMed Recent Development
    11.6 Curium Pharmaceuticals
        11.6.1 Curium Pharmaceuticals Company Details
        11.6.2 Curium Pharmaceuticals Business Overview
        11.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Introduction
        11.6.4 Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.6.5 Curium Pharmaceuticals Recent Development
    11.7 Jubilant DraxImage
        11.7.1 Jubilant DraxImage Company Details
        11.7.2 Jubilant DraxImage Business Overview
        11.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Introduction
        11.7.4 Jubilant DraxImage Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.7.5 Jubilant DraxImage Recent Development
    11.8 Lantheus
        11.8.1 Lantheus Company Details
        11.8.2 Lantheus Business Overview
        11.8.3 Lantheus Nuclear Drug for Therapeutic Introduction
        11.8.4 Lantheus Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.8.5 Lantheus Recent Development
    11.9 Spectrum Pharmaceuticals
        11.9.1 Spectrum Pharmaceuticals Company Details
        11.9.2 Spectrum Pharmaceuticals Business Overview
        11.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Introduction
        11.9.4 Spectrum Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.9.5 Spectrum Pharmaceuticals Recent Development
    11.10 Progenics Pharmaceuticals
        11.10.1 Progenics Pharmaceuticals Company Details
        11.10.2 Progenics Pharmaceuticals Business Overview
        11.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Introduction
        11.10.4 Progenics Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.10.5 Progenics Pharmaceuticals Recent Development
    11.11 International Isotopes
        11.11.1 International Isotopes Company Details
        11.11.2 International Isotopes Business Overview
        11.11.3 International Isotopes Nuclear Drug for Therapeutic Introduction
        11.11.4 International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2016-2021)
        11.11.5 International Isotopes Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Radium-223
    Table 3. Key Players of Lutetium-177
    Table 4. Key Players of Iodine-131
    Table 5. Key Players of Other
    Table 6. Global Nuclear Drug for Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Nuclear Drug for Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Nuclear Drug for Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Nuclear Drug for Therapeutic Market Share by Regions (2016-2021)
    Table 10. Global Nuclear Drug for Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Nuclear Drug for Therapeutic Market Share by Regions (2022-2027)
    Table 12. Nuclear Drug for Therapeutic Market Trends
    Table 13. Nuclear Drug for Therapeutic Market Drivers
    Table 14. Nuclear Drug for Therapeutic Market Challenges
    Table 15. Nuclear Drug for Therapeutic Market Restraints
    Table 16. Global Nuclear Drug for Therapeutic Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Nuclear Drug for Therapeutic Market Share by Players (2016-2021)
    Table 18. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Drug for Therapeutic as of 2020)
    Table 19. Ranking of Global Top Nuclear Drug for Therapeutic Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Nuclear Drug for Therapeutic Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Nuclear Drug for Therapeutic Product Solution and Service
    Table 23. Date of Enter into Nuclear Drug for Therapeutic Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2016-2021)
    Table 27. Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Nuclear Drug for Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2016-2021)
    Table 31. Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Nuclear Drug for Therapeutic Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Bayer Company Details
    Table 64. Bayer Business Overview
    Table 65. Bayer Nuclear Drug for Therapeutic Product
    Table 66. Bayer Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 67. Bayer Recent Development
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Nuclear Drug for Therapeutic Product
    Table 71. Novartis Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 72. Novartis Recent Development
    Table 73. China Isotope & Radiation Company Details
    Table 74. China Isotope & Radiation Business Overview
    Table 75. China Isotope & Radiation Nuclear Drug for Therapeutic Product
    Table 76. China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 77. China Isotope & Radiation Recent Development
    Table 78. Dongcheng Company Details
    Table 79. Dongcheng Business Overview
    Table 80. Dongcheng Nuclear Drug for Therapeutic Product
    Table 81. Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 82. Dongcheng Recent Development
    Table 83. Q BioMed Company Details
    Table 84. Q BioMed Business Overview
    Table 85. Q BioMed Nuclear Drug for Therapeutic Product
    Table 86. Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 87. Q BioMed Recent Development
    Table 88. Curium Pharmaceuticals Company Details
    Table 89. Curium Pharmaceuticals Business Overview
    Table 90. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product
    Table 91. Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 92. Curium Pharmaceuticals Recent Development
    Table 93. Jubilant DraxImage Company Details
    Table 94. Jubilant DraxImage Business Overview
    Table 95. Jubilant DraxImage Nuclear Drug for Therapeutic Product
    Table 96. Jubilant DraxImage Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 97. Jubilant DraxImage Recent Development
    Table 98. Lantheus Company Details
    Table 99. Lantheus Business Overview
    Table 100. Lantheus Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 101. Lantheus Recent Development
    Table 102. Spectrum Pharmaceuticals Company Details
    Table 103. Spectrum Pharmaceuticals Business Overview
    Table 104. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product
    Table 105. Spectrum Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 106. Spectrum Pharmaceuticals Recent Development
    Table 107. Progenics Pharmaceuticals Company Details
    Table 108. Progenics Pharmaceuticals Business Overview
    Table 109. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product
    Table 110. Progenics Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 111. Progenics Pharmaceuticals Recent Development
    Table 112. International Isotopes Company Details
    Table 113. International Isotopes Business Overview
    Table 114. International Isotopes Nuclear Drug for Therapeutic Product
    Table 115. International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2016-2021) & (US$ Million)
    Table 116. International Isotopes Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nuclear Drug for Therapeutic Market Share by Type: 2020 VS 2027
    Figure 2. Radium-223 Features
    Figure 3. Lutetium-177 Features
    Figure 4. Iodine-131 Features
    Figure 5. Other Features
    Figure 6. Global Nuclear Drug for Therapeutic Market Share by Application: 2020 VS 2027
    Figure 7. Thyroid Case Studies
    Figure 8. Bone Metastasis Case Studies
    Figure 9. Lymphoma Case Studies
    Figure 10. Other Case Studies
    Figure 11. Nuclear Drug for Therapeutic Report Years Considered
    Figure 12. Global Nuclear Drug for Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Nuclear Drug for Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Nuclear Drug for Therapeutic Market Share by Regions: 2020 VS 2027
    Figure 15. Global Nuclear Drug for Therapeutic Market Share by Regions (2022-2027)
    Figure 16. Global Nuclear Drug for Therapeutic Market Share by Players in 2020
    Figure 17. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Drug for Therapeutic as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Nuclear Drug for Therapeutic Revenue in 2020
    Figure 19. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2016-2021)
    Figure 20. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2022-2027)
    Figure 21. North America Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
    Figure 23. North America Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
    Figure 24. North America Nuclear Drug for Therapeutic Market Share by Country (2016-2027)
    Figure 25. United States Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
    Figure 29. Europe Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
    Figure 30. Europe Nuclear Drug for Therapeutic Market Share by Country (2016-2027)
    Figure 31. Germany Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Nuclear Drug for Therapeutic Market Share by Region (2016-2027)
    Figure 41. China Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
    Figure 49. Latin America Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
    Figure 50. Latin America Nuclear Drug for Therapeutic Market Share by Country (2016-2027)
    Figure 51. Mexico Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Nuclear Drug for Therapeutic Market Share by Country (2016-2027)
    Figure 57. Turkey Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Nuclear Drug for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Bayer Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 61. Novartis Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 62. China Isotope & Radiation Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 63. Dongcheng Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 64. Q BioMed Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 65. Curium Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 66. Jubilant DraxImage Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 67. Lantheus Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 68. Spectrum Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 69. Progenics Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 70. International Isotopes Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Frequently Asked Questions
Nuclear Drug for Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nuclear Drug for Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nuclear Drug for Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Artesunate Drugs

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quini ... Read More

Artesunate Medicines

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quini ... Read More